Adults with obesity (BMI ≥30) or with overweight (BMI ≥27) plus at least one weight-related condition.
- Once-weekly self-injection in the thigh, abdomen or upper arm.
- Dose is escalated step-wise (2.5 mg → 5 → 7.5 → 10 → 12.5 → 15 mg) every 4 weeks while the body adapts.
- Combined with diet and physical activity — tirzepatide complements, not replaces, lifestyle change.
- Severe abdominal pain radiating to the back (possible pancreatitis) — stop and seek urgent care.
- Gallbladder problems — sudden right-upper abdominal pain, jaundice, fever.
- Severe dehydration from prolonged vomiting / diarrhoea, risk of acute kidney injury.
- Sudden vision changes in patients with diabetic retinopathy.
- Severe allergic reaction.
WHEN TO CALL THE DOCTOR
Call us through the in-app chat if you notice…
- Severe or persistent vomiting, dehydration, or inability to eat for more than 48h.
- New, severe abdominal pain that doesn't ease — A&E first.
- Pregnancy or a positive pregnancy test — stop the medicine immediately.
- A new medication or condition since your last consultation.
OFFICIAL SOURCE
This summary is condensed from the regulator's full product leaflet for ease of reading. The complete document — every interaction, dose adjustment and reporting note — is one click away.
This page summarises information from the regulator-approved leaflet for reference only. It is not medical advice and does not replace the assessment of an EU-licensed doctor. Your doctor will review your individual history, dose and interactions during your consultation.
← Back to consultationYou can print this page for your records.